Pegvisomant and Improvement of Quality of Life in Acromegalic Patients

Publisher： Karger

E-ISSN： 1663-2826|76|1|102-105

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.76, Iss.1, 2011-07, pp. : 102-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Positive Metabolic Impact of Treatment with Pegvisomant in an Acromegalic Patient

By  

Hormone Research in Paediatrics, Vol. 67, Iss. 1, 2007-02 ,pp. : 174-176

Karger

Access to resources Recommend Favorite

Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism?

By  

European Thyroid Journal, Vol. 1, Iss. 3, 2012-09 ,pp. : 186-192

Karger

Access to resources Recommend Favorite

Pegvisomant Treatment in Acromegaly

By  

Neuroendocrinology, Vol. 103, Iss. 1, 2016-0 ,pp. : 59-65

Karger

Access to resources Recommend Favorite

The Cost of Medical Care for the Acromegalic Patient

By  

Neuroendocrinology, Vol. 83, Iss. 3-4, 2006-10 ,pp. : 139-144

Karger

Access to resources Recommend Favorite

Validation of the Tuebingen CD-25 Inventory as a Measure of Postoperative Health-Related Quality of Life in Patients Treated for Cushing's Disease

By  

Neuroendocrinology, Vol. 102, Iss. 1-2, 2015-05 ,pp. : 60-67

Karger

Access to resources Recommend Favorite